16 completed, 1 active not recruiting, 1 terminated, 1 withdrawn. 19 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 19 | Completed 16, Active not recruiting 1, Terminated 1, Withdrawn 1 |
Follow CellCept: new trials by email Literature Review of CellCept trials Research Report on CellCept
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effect of Eltrombopag on the Expression of Platelet Collagen Receptor GPVI in Pediatric ITP. Eltrombopag, conventional - Idiopathic Thrombocytopenic Purpura | Not applicable | Completed | Nayera Hazaa Elsherif | 36 | 2018-08-01 | 2021-10-28 |
| Clinical Study Evaluating Two Treatment Protocols for Immunosuppressive Drugs. Looking at 3-year Incidence of CLAD. Cyclosporine, Mycophenolate mofetil (MMF), Rabbit Anti thymocyte globulin - Lung Transplantation, Allografts | Not applicable | Active not recruiting | Vastra Gotaland Region | 249 | 2016-10-12 | 2023-04-26 |
| Initiation of a Deceased Donor Uterine Transplantation Program at the University of Nebraska Medical Center Uterine Transplant - Uterus Transplant | Not applicable | Withdrawn | University of Nebraska | 2016-01-01 | 2023-08-15 | |
| Prospective Donor Specific T Response Measurment for IS Minimization in de Novo Renal Transplantation Tacrolimus (for Group B), MMF (mycophenolate mofetil) (for Group B), 6-methyl prednisolone (Steroids) (for Group B) - Disorder Related to Renal Transplantation, Effects of Immunosuppressant Therapy | Not applicable | Completed | Prof. Dr. Petra Reinke | 184 | 2015-03-01 | 2021-02-01 |
| Low Dose Thymoglobulin to Protect Kidney Function After Liver Transplant Thymoglobulin 3mg total, Thymoglobulin 4.5mg total, Mycophenolate mofetil - Liver Transplantation | Not applicable | Completed | The Cleveland Clinic | 30 | 2009-08-01 | 2018-10-09 |
| Polycystic Liver Disease in Kidney Transplant Tacrolimus, Sirolimus, Mycophenolate Mofetil - Polycystic Liver Disease | Not applicable | Terminated | Mayo Clinic | 2 | 2009-02-01 | 2013-03-08 |
| A Prospective Study on the Tolerability and Efficacy of the de Novo Use of Myfortic in Liver Transplant Recipients Myfortic, CellCept - Immunosuppression | Not applicable | Completed | University of Pittsburgh | 30 | 2006-11-01 | 2017-03-09 |
| Bioequivalency Study of Mycophenolate Mofetil 500 mg Tablets Under Fasted Conditions Mycophenolate Mofetil - Prophylaxis of Organ Rejection | Not applicable | Completed | Roxane Laboratories | 38 | 2006-01-01 | 2018-01-23 |
| Bioequivalency Study of Mycophenolate Mofetil 500 mg Tablets Under Fed Conditions Mycophenolate Mofetil - Prophylaxis of Organ Rejection | Not applicable | Completed | Roxane Laboratories | 39 | 2006-01-01 | 2018-01-23 |
| Bioequivalency Study of Mycophenolate Mofetil 250 mg Capsules Under Fed Conditions mycophenolate mofetil - Prophylaxis of Organ Rejection | Not applicable | Completed | Roxane Laboratories | 37 | 2005-11-01 | 2018-01-23 |
| Bioequivalency Study of Mycophenolate Mofetil 250 mg Capsules Under Fasted Conditions Mycophenolate Mofetil - Prophylaxis of Organ Rejection | Not applicable | Completed | Roxane Laboratories | 37 | 2005-11-01 | 2018-01-23 |
| Exchange of Azathioprine by Mycophenolatmofetile and Cyclosporine A Dose Reduction After Heart Transplantation Mycophenolatmofetile, Cyclosporin A - Heart Transplantation | Not applicable | Completed | Hannover Medical School | 23 | 2004-11-01 | 2009-02-16 |
| Withdrawal of Steroids, Cyclosporine A Dose Reduction and Switch to Mycophenolatmofetile After Heart Transplantation prednisolon, Mycophenolatmofetile, Cyclosporin A - Heart Transplantation | Not applicable | Completed | Hannover Medical School | 40 | 2004-11-01 | 2009-02-13 |
| Pilot Trial for Implementation of a MPA PK Monitoring Strategy Mycophenolate mofetil + Tacrolimus, Mycophenolate mofetil + Cyclosporin - Transplant, Kidney | Not applicable | Completed | University of Florida | 24 | 2003-07-01 | 2011-10-20 |
| Pediatric Kidney Transplant Without Calcineurin Inhibitors Daclizumab, Methylprednisolone/prednisone, Mycophenolate mofetil - End-Stage Renal Disease | Not applicable | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 35 | 2001-02-01 | 2016-10-21 |
| Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies fludarabine phosphate, total-body irradiation, peripheral blood stem cell transplantation - Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia | Not applicable | Completed | Fred Hutchinson Cancer Center | 160 | 2000-12-01 | 2020-01-21 |
| Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer fludarabine phosphate, total-body irradiation, peripheral blood stem cell transplantation - Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia | Not applicable | Completed | Fred Hutchinson Cancer Center | 5 | 1999-11-01 | 2017-05-24 |
| Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer fludarabine phosphate, total-body irradiation, nonmyeloablative allogeneic hematopoietic stem cell transplantation - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission | Not applicable | Completed | Fred Hutchinson Cancer Center | 55 | 1999-11-01 | 2019-09-10 |
| Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma chemotherapy, total-body irradiation, peripheral blood stem cell transplantation - Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma | Not applicable | Completed | Fred Hutchinson Cancer Center | 63 | 1997-09-01 | 2019-12-27 |
Leukemia, Lymphocytic, Chronic, B-Cell (4) · Lymphoma, B-Cell, Marginal Zone (4) · Lymphoma, Follicular (4) · Lymphoma, Non-Hodgkin (4) · Lymphoma, T-Cell, Cutaneous (4) · Multiple Myeloma (4) · Mycosis Fungoides (4) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (4) · Sezary Syndrome (4) · Waldenstrom Macroglobulinemia (4) · Burkitt Lymphoma (3) · Congenital Abnormalities (3) · Hodgkin Disease (3) · Immunoblastic Lymphadenopathy (3) · Intraocular Lymphoma (3)
Fred Hutchinson Cancer Center (4) · Roxane Laboratories (4) · Hannover Medical School (2) · Mayo Clinic (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Nayera Hazaa Elsherif (1) · Prof. Dr. Petra Reinke (1) · The Cleveland Clinic (1) · University of Florida (1) · University of Nebraska (1) · University of Pittsburgh (1) · Vastra Gotaland Region (1)
United States (13) · Germany (6) · Italy (2) · Czechia (1) · Denmark (1) · Egypt (1) · Finland (1) · France (1) · Netherlands (1) · Norway (1) · Spain (1) · Sweden (1) · United Kingdom (1)
Christoph Bara, Dr. med. (2) · David Maloney (2) · William Allan Alexander, M.D. (2) · William Allen Alexander, M.D. (2) · Alexander T Maskin, MD (1) · Ann Woolfrey (1) · Azza AG Tantawy, MD (1) · Bijan Eghtesad, MD (1) · Brenda Sandmaier (1) · Herwig-Ulf Meier-Kriesche, MD (1) · Michael E de Vera, MD (1) · Patrick Dean, M.D. (1) · QI Qian, MD (1)
PMID 32499241, PMID 11919310, PMID 12359731, PMID 15049798, PMID 16382014, PMID 16687625, PMID 17452226, PMID 18698002, PMID 19005182, PMID 20148887, PMID 20671616, PMID 21538345, PMID 23361904, PMID 23454241, PMID 24674813, PMID 26231455, PMID 26477577, PMID 2665875, PMID 26688484, PMID 27403440, PMID 28627134, PMID 37703908, PMID 40118141
P30CA015704 (4), P01CA018029 (2), 2014 (1), 2015 (1), 2019 (1)